Currently , there are two major types of drugs in the first-line treatment of ovarian cancer : paclitaxel , which hinders cancer cell division by inhibiting the disassembly of microtubules ; and carboplatin , which binds to and causes crosslinking of dna that results in the death of cancer cells .
